EUCTR2009-011816-39-GB进行中（未招募）1 期
A randomised, open label, prospective study to assess two different therapeutic strategies following first treatment failure in HIV-1 infected subjects. ‘The First Failure Study’ : ‘FAST’ - The First Failure Study
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •HIV-1 infected males or females
- •over 18 years of age
- •signed informed consent
- •currently receiving a stable antiretroviral regimen comprising of:
- •- two or more licensed NRTIs
- •- one licensed NNRTI or boosted protease inhibitor
- •no previous protease inhibitor resistance documented on HIV-1 genotypic resistance testing
- •failure of current antiretroviral regimen due to:
- •- toxicity, intolerance or virological failure if receiving an NNRTI containing regimen at screening
- •- toxicity or intolerance if receiving a boosted-protease inhibitor regimen at screening (with plasma HIV RNA < 400 copies/mL at screening)
- •willing to modify antiretroviral therapy, in accordance with the randomisation assignment
- •no previous exposure to etravirine
- •subjects in good health upon medical history, physical exam, and laboratory testing in the opinion of the investigator
- •have no serologic evidence of active HBV infection evidenced by negative hepatitis B surface antigen
- •female subjects who are heterosexually active and of childbearing potential (i.e., not surgically sterile or at least two years post menopausal) must practice contraception as follows from screening through completion of the study:
- •- barrier contraceptives (condom, diaphragm with spermicide)
- •- IUD or Depo PLUS a barrier contraceptive
- •- female subjects of childbearing potential must have a negative pregnancy test.
- •Lumbar puncture sub study:
- •as per main study
- •no contraindication to lumbar puncture examination
- •no other medication
- •no switches in antiretroviral therapy outside study treatment arms
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •current alcohol abuse or drug dependence
- •pregnancy
- •active opportunistic infection or significant co-morbidities
- •current prohibited concomitant medication (as listed in section 4.1.4)
- •a likelihood of diminished response to any of the study treatment arms, in the opinion of the investigator, based on HIV genotypic resistance testing
研究者
相似试验
已完成
4 期
A clinical trial to compare the safety and efficacy of CNI's and sirolimus in renal transplant recipientsCTRI/2011/091/000034Biocon Limited60
尚未招募
3 期
Saroglitazar and Fenofibrate in diabetic dyslipidemiaCTRI/2021/03/031900Endolife Specialty Hospital
已完成
不适用
An open-label, randomized, study comparing safety and efficacy of multi-strain probiotic with single- strain probiotics or no probiotics in acute diarrhea in children 02- 12 years of age in IndiaCTRI/2020/01/022609CTQuest LLP52
尚未招募
不适用
An open-label, prospective randomized trial to assess the non-inferiority of diuretic effect of tolvaptan as an alternative agent to loop diuretics in chronic heart failure.chronic heart failureJPRN-UMIN000026331Department of Cardio-Renal Medicine and Hypertension, Graduate School of Medical Sciences, Nagoya City University, Japan200
招募中
4 期
Postoperative comparison of Sterizone® dressing versus standard gauze dressing in women having cesarean sectioCTRI/2022/10/046881Dynamic Techno Medicals Private Limited